Browsing Research Articles (Immunology) by Subject "Vaccines"

Browsing Research Articles (Immunology) by Subject "Vaccines"

Sort by: Order: Results:

  • Access to novel therapies for COVID-19 – distributive justice and Russian roulette? 
    Pepper, Michael Sean (Health and Medical Publishing Group, 2020-12)
    In an ideal world, universal access to healthcare should be achievable; all COVID-19 patients should have access to therapies that improve outcomes. These include existing, repurposed and novel therapies. Novel therapies ...
  • Multifaceted role of pneumolysin in the pathogenesis of myocardial injury in community-acquired pneumonia 
    Anderson, Ronald; Nel, Jan Gert; Feldman, Charles (MDPI Publishing, 2018-04-11)
    Pneumolysin (PLY), a member of the family of Gram-positive bacterial, cholesterol-dependent, -barrel pore-forming cytolysins, is the major protein virulence factor of the dangerous respiratory pathogen, Streptococcus ...
  • SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals 
    Richardson, Simone I.; Madzorera, Tatenda; Spencer, Holly; Manamela, Nelia P.; Van der Mescht, Mieke Adri; Lambson, Bronwen E.; Oosthuysen, Brent; Ayres, Frances; Makhado, Zanele; Moyo-Gwete, Thandeka; Mzindle, Nonkululeko; Motlou, Thopisang; Strydom, Amy; Mendes, Adriano; Tegally, Houriiyah; De Beer, Zelda; De Villiers, Talita Roma; Bodenstein, Annie; Van den Berg, Gretha; Venter, Marietjie; De Oliviera, Tulio; Ueckermann, Veronica; Rossouw, Theresa M.; Boswell, M.T.; Moore, Penny L. (Cell Press, 2022-03-24)
    The SARS-CoV-2 Omicron variant escapes neutralizing antibodies elicited by vaccines or infection. However, whether Omicron triggers cross-reactive humoral responses to other variants of concern (VOCs) remains unknown. We ...
  • SARS-CoV-2 variants, vaccines, and host immunity 
    Mistry, Priyal; Barmania, Fatima; Mellet, Juanita; Peta, Kimberly; Strydom, Adele; Viljoen, Ignatius M.; James, William; Gordon, Siamon; Pepper, Michael Sean (Frontiers Media SA, 2022-01-03)
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta coronavirus that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes coronavirus disease 2019 (COVID-19) and was declared ...